![]() |
Speciality Formulations |
NO. |
NAME OF THE PRODUCT |
COMPOSITION |
THERAPEUTIC APPLICATION |
USES | ADVANTAGES |
1 |
ALKAY-ER TABLETS (Potassium Chloride Extended Release Tablets USP 600 mg) |
Each coated tablet contains: |
Electrolyte Replinishers |
In the treatment of hypokalemia, with or without metabolic alkalosis, in digitalis intoxication. |
Sustained blood levels Attenuation of adverse effects Improved patient compience Reduction in frequency of administration |
2 |
Morphine Sulphate Slow Release Tablets 15mg |
Each sustained release tablet contains : |
Narcotic Analgesic |
For the relief of severe acute & severe chronic pain as well as long-term pain |
It maintains steady levels of drugs in the blood. |
3 |
RILIMORF - 30 - SR (Morphine Sulphate Slow Release Tablets 30mg) |
Each sustained release tablet contains: |
Narcotic Analgesic |
For the relief of severe acute & severe chronic pain as well as long-term pain |
It maintains steady levels of drugs in the blood. |
4 |
Sulfasalazine Delayed release tablets U.S.P. 500mg |
Each enteric coated tablet contains
: |
Non-steroidal |
In the treatment of severe ulcerative colitis, proctitis or distal ulcerative colitis and Crohn's disease. |
After administration it gradually releases active ingredients and shows effects for prolong period of time. |
5 | Indomethacin Extended Release Capsules U.S.P. 75 mg |
Each Extended Release Capsule contains: |
Non-steroidal Anti-inflamatory |
Used for symptomatic relief of moderate to severe rheumatoid arthritis
, ankylosing spondylitis, |
Sustained blood levels Attenuation of adverse effects Improved patient compience (Reduction in frequency of administration) |
Patents : Products protected by valid patents are not
offered for sale in countries where the sale of such products constitutes a
patent infringement and the liability for patent infringement is
exclusively understood at buyer’s risk.